Roche reminds the markets that it's a Kras player

Retrieved on: 2021-04-21 13:52:30

Tags for this article:

Click the tags to see associated articles and topics

Roche reminds the markets that it's a Kras player. View article details on hiswai:

Excerpt

A low-key footnote to Roche's first-quarter financials today revealed that the group had put RG6333, a Shp2 inhibitor, into a phase 1 trial.

Article found on: www.evaluate.com